DURECT Corporation to Participate in Upcoming Healthcare C...( CUPERTINO Calif. Oct. 28 /- DUREC...),Health
Navigation Links
DURECT Corporation to Participate in Upcoming Healthcare Conferences
Date:10/28/2008
CUPERTINO, Calif., Oct. 28 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that management is scheduled to present at the following upcoming healthcare conferences in New York, NY.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)
-- Oppenheimer 19th Annual Healthcare Conference on Tuesday, November 4th at 3:20 p.m. Eastern Time.
-- Barclays Capital Small & Mid-Cap Healthcare Forum on Thursday, November 6th at 2:30 p.m. Eastern Time.
-- Rodman & Renshaw Annual Global Healthcare Conference on Tuesday, November 11th 5:20 p.m. EST.
A live audio webcast of the presentations will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.
About DURECT Corporation
DURECT is an emerging specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY(R), POSIDUR(TM), ELADUR(TM) and TRANSDUR(TM)-Sufentanil. DURECT's proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit http://www.durect.com.
NOTE: POSIDUR(TM), SABER(TM), ORADUR(R), TRANSDUR(TM) and ELA
'/>"/>
| SOURCE DURECT Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. DURECT Corporation Invites You to Join Its Third Quarter 2008 Earnings Conference Call
2. DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
3. DURECT Corporation Invites You to Join Its Second Quarter 2008 Earnings Conference Call
4. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
5. DURECT Corporation Invites You to Join Its First Quarter 2008 Earnings Conference Call
6. DURECT to Participate in Morgan Stanley Global Healthcare Conference
7. DURECT Provides Update on CHRONOGESIC(R) Research Program
8. DURECT to Participate in Cowen Annual Healthcare Conference
9. DURECT to Participate in Susquehanna Financial Healthcare Conference
10. DURECT to Present at BIO CEO Investor Conference 2008
11. DURECT to Present at 2007 BIO Investor Forum
Post Your Comments:
(Date:12/3/2009)... , BEVERLY HILLS, Calif., Dec. 3 /PRNewswire/ -...ear,s Divine Design Gala and Premier Shopping Even...priced at 50-70% off regular prices. The event ki...onday, December 7, 2009, located at 9900 Wilshire ... California. Please visit www.divinedesign.org ...
(Date:12/3/2009)...in outperforms widely used sulfonylureas, but each... , THURSDAY, Dec. 3 (HealthDay News) -- A class ...pe 2 diabetes is associated with a higher risk of ...etformin, researchers say. , , Sulfonylureas, l...ss well than metformin in a study of oral anti-dia...
(Date:12/3/2009)... Economic downturn causes demand...ountainside in Connecticut cites a sharp increase ...aused by economic crisis which has led to an incre...rital problems. , (PRWEB)...tion Treatment Center sees a huge spike in demand ...
(Date:12/3/2009)... , FREMONT, Calif., Dec. 3 /PRNewswire-USNewswi...h (AACR) released findings today from one of the l...st cancer in women conducted by the Northern Cali...evealed that women who never smoked cigarettes and...er a lifetime--especially during adulthood--had a ...
(Date:12/3/2009)... , PASADENA, Calif., Dec. 3 ...usinesses, the risk of disability remains one of t...onal financial well being, but also their business...declines have taken their toll, owners of small bu...r financial safety net with enhanced disability co...
Breaking Medicine News(10 mins):Health News:Christian Audigier Represented at Divine Design for Project Angel Food 2Health News:Diabetes Drugs Go Head-to-Head in Study 2Health News:Diabetes Drugs Go Head-to-Head in Study 3Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4[0] Christian Audigier Represented at Divine Design for Project Angel Food[0] Diabetes Drugs Go Head-to-Head in Study[0] Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment [2] Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research[1] New Disability Income Insurance Options Provide More Choice for California's Small Business Owners
...6% reduction in time awake and a drop in anxiety l...s) -- A session of moderate aerobic exercise can h...p for insomnia patients, according to a Brazilian ... and eight men with primary chronic insomnia into ...
...Robbins & Myers, Inc.,(NYSE: RBN ) announced toda...08 financial results for the period ended May 31, ...08. A live webcast of the conference call is,sched...ancial Officer. They will discuss the Company,s pe...
...d Have Improved Benefits for Prevention, Mental,He...ugh National,E-Prescribing, HARRISBURG, Pa., June...blocked critical legislation to protect and,improv...,s prevention, mental health, and low-income progr...
... Vote to Block Medicare Improvement Bill, Biparti...ntion, Mental,Health and Low-Income Programs, Boos...MORE, June 12 The following was issued,today by A...,who depend on it. The Medicare Improvements for P...
...l report faults FDA on food safety , , THU...eople sickened in the ongoing outbreak of salmonel...ates, with 25 hospitalizations, U.S. health offici... of protecting the nation,s food supply. , The inv...
... that will allow physicians to more accurately dia...censed by Emory University to Syntermed, an Atlant...oftware company. The software uses multiharmonic p...liably determine which heart failure patients will...
Other Medicine News:Health News:AARP PENNSYLVANIA NEWS ALERT: AARP Dismayed by Senate Vote to Block Medicare Improvement Bill 2Health News:AARP PENNSYLVANIA NEWS ALERT: AARP Dismayed by Senate Vote to Block Medicare Improvement Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 2Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 3Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 4Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 5Health News:Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients 2Moderate Aerobics May Ease Insomnia Symptoms Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference CallAARP PENNSYLVANIA NEWS ALERT: AARP Dismayed by Senate Vote to Block Medicare Improvement BillAARP Maryland Key Vote News Alert228 People in 22 States Sickened in Ongoing Salmonella-Tomato OutbreakSyntermed licenses Emory imaging technology for improved evaluation of heart failure patients
(Date:12/3/2009)... , WARRENDALE, Pa., Dec. 3 Radi...S* injection-record integration capabilities at th... in Chicago. The Connect.PACS(TM) product, enab...of its kind, is the latest release in the company,... . ,, (Photo: http://www.newscom.com/cgi-bi...
(Date:12/3/2009)..., HOERSHOLM, Denmark and SAN DIEGO, Califor...49 Successfully Inhibits miR-122, a microRNA Impor...gnificantly Reducing Hepatitis C,Virus in the Bloo...he,Hepatitis C Virus , - SPC3649 Demonstr... and,No Serious Adverse Events in the Treated Anim...
(Date:12/3/2009)...HAM, N.C., Dec. 3 In re...care information technologies in the evolving heal...the Duke Center for Health Informatics (DCHI) to p... will oversee an innovative interdisciplinary appr...on of physicians, nurses and healthcare administra...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 1Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 2Delta Health an InfoLogix Company Wins Engagement with Hennepin County Medical Center for Strategic Cost Management 56400 3New York Giants to Host American Red Cross Blood Drive 56398 1New York Giants to Host American Red Cross Blood Drive 56398 2First Ever NJ Psoriasis Walk Coming to Paramus on Sept 12 56396 1First Ever NJ Psoriasis Walk Coming to Paramus on Sept 12 56396 2[0] MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009[0] New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C[0] Duke Medicine to Train Healthcare Professionals in Health Informatics
...erve as international hub for collaborative resear...own, the Wayne State University research and tec...cell commercialization lab in Michigan. The Wayne ...rainchild of Wayne County Executive Robert Ficano,... the 2,500-square-foot stem cell research facility...
...hen and Clarify BLA Data , , FDA Extends PDUFA A...t Conference Call , , EAST BRUNSWICK, N.J., Feb...T ) today announced that the Company filed amendme... the previously submitted pegloticase Biologics Li...y review. The amendments focus on topics identifie...
Other Medicine Technology:Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab' 2Savient Provides Update on Pegloticase BLA 2Savient Provides Update on Pegloticase BLA 3Savient Provides Update on Pegloticase BLA 4Savient Provides Update on Pegloticase BLA 5Savient Provides Update on Pegloticase BLA 6Savient Provides Update on Pegloticase BLA 7Savient Provides Update on Pegloticase BLA 8Savient Provides Update on Pegloticase BLA 9| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |